Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
Europe
0
Australia
0
South Africa
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector


1. Codinovo
2. Dicodid
3. Dihydrocodeinone
4. Hycodan
5. Hycon
6. Hydrocodeinonebitartrate
7. Hydrocodon
8. Hydrocodone
9. Hydrocodone Tartrate (1:1), Hydrate (2:5)
10. Hydrocon
11. Robidone
1. (4r,4ar,7ar,12bs)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;2,3-dihydroxybutanedioic Acid
2. .codon
3. Schembl154972
4. Chembl2062267
1. Hydrocone
2. Multacodin
3. Hydrocodone
| Molecular Weight | 449.4 g/mol |
|---|---|
| Molecular Formula | C22H27NO9 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 4 |
| Exact Mass | 449.16858144 g/mol |
| Monoisotopic Mass | 449.16858144 g/mol |
| Topological Polar Surface Area | 154 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 642 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Antitussive Agents
Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
75
PharmaCompass offers a list of Hydrocodone Bitartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Hydrocodone Bitartrate manufacturer or Hydrocodone Bitartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hydrocodone Bitartrate manufacturer or Hydrocodone Bitartrate supplier.
A TYCOLET-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of TYCOLET-1, including repackagers and relabelers. The FDA regulates TYCOLET-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. TYCOLET-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of TYCOLET-1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A TYCOLET-1 supplier is an individual or a company that provides TYCOLET-1 active pharmaceutical ingredient (API) or TYCOLET-1 finished formulations upon request. The TYCOLET-1 suppliers may include TYCOLET-1 API manufacturers, exporters, distributors and traders.
click here to find a list of TYCOLET-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A TYCOLET-1 DMF (Drug Master File) is a document detailing the whole manufacturing process of TYCOLET-1 active pharmaceutical ingredient (API) in detail. Different forms of TYCOLET-1 DMFs exist exist since differing nations have different regulations, such as TYCOLET-1 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A TYCOLET-1 DMF submitted to regulatory agencies in the US is known as a USDMF. TYCOLET-1 USDMF includes data on TYCOLET-1's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The TYCOLET-1 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of TYCOLET-1 suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a TYCOLET-1 Drug Master File in Korea (TYCOLET-1 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of TYCOLET-1. The MFDS reviews the TYCOLET-1 KDMF as part of the drug registration process and uses the information provided in the TYCOLET-1 KDMF to evaluate the safety and efficacy of the drug.
After submitting a TYCOLET-1 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their TYCOLET-1 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of TYCOLET-1 suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing TYCOLET-1 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for TYCOLET-1 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture TYCOLET-1 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain TYCOLET-1 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a TYCOLET-1 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of TYCOLET-1 suppliers with NDC on PharmaCompass.
TYCOLET-1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of TYCOLET-1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right TYCOLET-1 GMP manufacturer or TYCOLET-1 GMP API supplier for your needs.
A TYCOLET-1 CoA (Certificate of Analysis) is a formal document that attests to TYCOLET-1's compliance with TYCOLET-1 specifications and serves as a tool for batch-level quality control.
TYCOLET-1 CoA mostly includes findings from lab analyses of a specific batch. For each TYCOLET-1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
TYCOLET-1 may be tested according to a variety of international standards, such as European Pharmacopoeia (TYCOLET-1 EP), TYCOLET-1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (TYCOLET-1 USP).